Filing Details
- Accession Number:
- 0001225208-25-002921
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-04 19:52:12
- Reporting Period:
- 2025-02-28
- Filing Date:
- 2025-03-04
- Accepted Time:
- 2025-03-04 19:52:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1739940 | Cigna Group | CI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1492663 | S Nicole Jones | 900 Cottage Grove Road Bloomfield CT 06002 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 Par Value | Acquisiton | 2025-02-28 | 9,064 | $0.00 | 36,287 | No | 4 | A | Direct | |
| Common Stock, $.01 Par Value | Acquisiton | 2025-02-28 | 3,147 | $0.00 | 39,434 | No | 4 | A | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2025-02-28 | 949 | $305.86 | 38,485 | No | 4 | F | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2025-02-28 | 4,160 | $305.86 | 34,325 | No | 4 | F | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2025-03-03 | 4,904 | $308.12 | 29,421 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, $.01 Par Value | Employee Stock Option (Right to Buy) | Acquisiton | 2025-02-28 | 11,176 | $0.00 | 11,176 | $305.86 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 11,176 | 2026-03-01 | 2035-02-28 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $.01 Par Value | 1,406 | Indirect | By 401(k) |
Footnotes
- The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2022-2024 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
- These restricted shares vest in three equal annual installments beginning March 1, 2026.
- Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.
- Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2024.
- Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.
- This option vests in three equal annual installments beginning March 1, 2026.
Billionaire Hedge Funds
